Abstract
Purpose
In-the-field projects aiming to improve quality in cancer control provide a valuable complement to health services and knowledge translation (kt) research studies. The present paper describes the methods used to develop the Knowledge Translation for Cancer Control in Canada: A Casebook and its results.
Methods
Nominations for in-the-field projects were accepted from individuals and organizations across Canada. The nominations had to demonstrate that a specific cancer control problem was identified; that a deliberate and organized effort was developed and implemented to address the identified problem; and that an evaluation—formal or informal—was used to assess the effort. A selection of nominated cases were chosen for more comprehensive analysis.
Results
Thirty nominations were received. Most tackled problems related to treatment or diagnosis. Challenges related to breast, gastrointestinal, and genitourinary cancer were most common among the disease-specific projects, and most projects were regional in scope, with strategies targeting organizational solutions. Of the 30 nominations, 19 were chosen for further analysis. Of those 19, 5 were influenced by a kt model or theory, and 16 reported formal evaluation strategies. Surveys were the most common evaluation method, and process outcomes and clinical surrogate outcomes were the most frequently cited. Financial and administrative challenges were most often cited as key barriers. The key lessons learned concerned the need for a collaborative high-functioning team, project management, and support.
Conclusions
The casebook provides tangible examples of in-the-field efforts to improve cancer control and provides practical direction for other individuals and institutions facing similar challenges. We discuss the interface between field projects and research projects in the kt arena and how mutual learning can help to optimize the value of each approach.
Keywords: Knowledge translation, practice, research, cancer control, casebook
1. INTRODUCTION
Across the cancer-control continuum, several research advances have emerged that can result in a reduction in disease incidence, mortality, and morbidity. These include the introduction of innovative screening and early detection maneuvers, effective new treatments, and strategies to improve quality of life 1–9. However, uptake and application of any clinical advancement or system improvement can be challenging and variable, with rates that are less than ideal 10,11.
Knowledge translation (kt) research can be used to help address those challenges. The Canadian Institutes of Health Research defines kt as a “dynamic and iterative process that includes synthesis, dissemination, exchange and ethically-sound application of knowledge to improve the health of Canadians, provide more effective health services and products and strengthen the health care system” 12. Scientific advances within the kt field have led to new understandings of the determinants of knowledge use, methods to measure knowledge use, and interventions to increase the uptake of knowledge, among others 13,14. For example, sound research principles have led to a better understanding of which interventions within cancer control are more and less effective at improving the application of knowledge by patients or clients, health care providers, and organizations 14,15. Indeed, a suite of high-quality knowledge synthesis strategies and qualitative and quantitative research methods are available for use in advancing the field. Although necessary and important, exploration of improvements in cancer control strictly through the lens of what can be learned from a research paradigm will miss other key sources of knowledge that are relevant to advancing that goal.
As a complement to research studies, quality improvement activities aim to solve a specific clinical or organizational problem 16. The goal of research is to generate new knowledge or to test specific hypotheses posed by the investigators. In contrast, quality improvement activities aim to solve a specific problem in a specific context. Quality improvement initiatives can be valuable by providing useful direction to groups and individuals who face similar problems and challenges in other contexts. It is acknowledged that quality improvement projects and kt efforts share some of the same goals and processes 17.
A comprehensive kt research initiative, the Knowledge Translation to Improve Quality of Cancer Control in Canada: What We Know and What is Next (that is, the “KT in Cancer Project”) examined both published kt literature in cancer control and in-the-field projects that aimed to find solutions to practical cancer-control challenges faced by various organizations, regions, and provinces—in other words, both the science and the practice of kt in cancer control. By considering both the science and the practice of kt, the goal of the initiative was to develop a comprehensive profile of the state of kt in cancer control. To that end, we organized our research activities into three modules:
Review of systematic reviews: A review and analysis of systematic reviews in the published scientific literature
kt models and frameworks: A review and analysis of selected kt models and frameworks that would be useful in guiding kt activities in cancer control
Casebook: An overview of in-the-field projects within Canada aiming to improve cancer control
The present paper describes the methods used to develop the casebook, its results, its interface with the kt research environment, and its potential use as an integral part of improving the quality of cancer care and cancer system performance.
2. METHODS
Casebook development represented one component of the overall KT in Cancer Project, a research initiative funded by the Ontario Institute for Cancer Research and the Canadian Partnership Against Cancer. Design, execution, and reporting of the initiative was editorially independent from the funders. The Canadian Institutes of Health Research casebook report served as the initiative’s methodologic and reporting foundation 18.
2.1. Defining Eligible Projects
The goal was to collect in-the-field projects from across Canada. To mitigate potential barriers in the nomination process that may emerge when labels or language are used, specific terms such as “knowledge translation projects” or “quality improvement projects” were avoided in requests to participants. Instead, the focus was on defining features of the in-the-field projects being sought. These were the nomination criteria for projects:
Identification of a specific cancer control problem
Development and implementation of a deliberate and organized effort to address the identified problem
Use of an evaluation—formal or informal—to assess the effort undertaken
Nominations addressing any stage in the cancer continuum or any cancer diagnosis were considered.
2.2. Participants
At the start, the initiative focused on gathering projects in Ontario, but the Canadian Partnership Against Cancer contributed funds to further expand the initiative to include a pan-Canadian perspective. As such, the goal was to ensure that field projects from across Canada were received. To achieve that goal, key leaders from each province and territory (see Appendix A, which can be found online at www.current-oncology.com/index.php/oncology/article/view/831/615) were solicited to self-nominate or to nominate others whose projects met the eligibility criteria already described.
2.3. Developing the Profile
Between February and April 2010, a letter requesting nominations of Canadian in-the-field projects was circulated by e-mail to eligible participants. The letter outlined the objective of the initiative and the 3 criteria to be met for a nomination to be considered. A nomination form was included with the letter, and a maximum of 2 nominations were requested from each participant. The key partners who had been contacted were requested to respond within 2 weeks of receiving the letter; if a response was not received, subsequent reminders were sent by e-mail.
On the nomination form, participants were asked to provide the name of the project, a short description of the project and how it met the eligibility criteria, and the contact information details for the project.
Upon receiving nominations, the research team reviewed them and selected some for a more enhanced profile and more detailed data collection. Criteria for selecting a nomination for further profiling included coverage of the continuum of care, jurisdiction, diagnoses, and stage of implementation or evaluation (or both). Projects further along in the process (implementation or evaluation) were chosen over projects still in development or in their early stages. For the projects selected for further profiling, the research team completed the profile using the information in the nomination form and information uncovered by researching the project using electronic databases and the Internet. Completed profile drafts were sent to the project lead or leads, accompanied by a covering letter containing information about the project and a legend of the profile’s data fields. The project lead was asked to review the profile and to provide any additional information to complete the profile. An iterative process was used to reach the final project profile.
2.3. Data and Analysis
All projects were coded for stage in the continuum of care (prevention, screening, diagnosis, treatment, palliative and end-of-life care, follow-up, survivor-ship, supportive care, and other or not specified), jurisdiction (national, provincial, regional), relevant cancer diagnosis, and scope (professional, consumer, organizational, financial, regulatory). Each project profile included data about the details of the problem that was to be solved, the barriers to solving the problem, the solution (intervention, target, outcomes), whether a model or framework was used to guide the project, the evaluation plan, the impact of the project, implications for resources, the tools and resources developed, and the lessons learned.
In a subsequent thematic analysis, 3 members of the team (MCB, JM, KG) reviewed each project profile and independently identified specific themes related to use of models and frameworks, evaluation processes, barriers to implementation (using the Légaré barriers framework 19), development of tools, and lessons learned. The themes were compared and contrasted between the researchers, and a final interpretation was determined by consensus.
3. RESULTS
3.1. Overall
The initiative received 30 nominations of kt or in-the-field projects 20 (see Appendix B, which can be found online at www.current-oncology.com/index.php/oncology/article/view/831/616). Table i provides a descriptive summary of the nominations, including details on the stage in the continuum of care, cancer diagnoses, jurisdiction, and focus.
TABLE I.
Descriptive criteria | Nominations (n) |
---|---|
Continuum of care | |
Prevention | 3 |
Screening | 3 |
Diagnosis | 7 |
Treatment | 11 |
Palliative care/end-of-life | 2 |
Follow-up | 0 |
Survivorship | 0 |
Supportive care | 5 |
Not specified/other | 7 |
Cancer diagnosis | |
Breast | 10 |
Gastrointestinal | 8 |
Genitourinary | 7 |
Head and neck | 4 |
Hematology | 1 |
Lung | 4 |
Melanoma | 1 |
Neuro-oncology | 1 |
Sarcoma | 1 |
Other | 2 |
Not specified | 16 |
Jurisdiction—scope | |
National | 1 |
Provincial | 7 |
Regional | 19 |
Jurisdiction—location | |
Atlantic | 4 |
Quebec | 2 |
Ontario | 22 |
Central Canada | 3 |
British Columbia | 3 |
Focus | |
Professional | 10 |
Consumer/patient | 8 |
Organizational | 22 |
Financial | 0 |
Regulatory | 1 |
With respect to stage of the cancer continuum, most nominations addressed a treatment-related (n = 11) or diagnosis (n = 7) problem (sometimes both), and none addressed a problem of follow-up or survivorship. Stage in the continuum was not relevant to 7 nominations, and 6 nominations targeted an issue relevant to 2 or more stages. Nominations were most likely to address problems associated with breast cancer (n = 10), gastrointestinal cancer (n = 8), or genitourinary cancer (n = 7) and least likely, problems associated with melanoma and sarcoma (n = 1 each) or neurologic and hematologic cancers (n = 1 each). Cancer diagnosis was not relevant to 16 nominations; 8 nominations addressed 2 or more cancer sites. Most projects originated in Ontario (n = 22), and most were regional in scope (n = 19). Finally, most nominations targeted organizational strategies to solve the problem (n = 22); none targeted financial strategies to solve the problem. Ten nominations focused on more than one strategy.
3.2. Field Projects
Of the initial 30 projects, 19 were selected for a more detailed analysis and a comprehensive project profile (see Appendix B: www.current-oncology.com/index.php/oncology/article/view/831/616).
3.3. Models and Frameworks
Few of the 19 projects used a theory or framework to guide development and execution of the project. Indeed, such tools were used in only 5 projects. Diffusion of Innovation, Institute for Heath Improvement Collaborative Model for Breakthrough Improvement, and educational theories were the identified models and theories cited. Evidence-based medicine and an integrated kt approach were also cited as guiding principles. Three projects reported creating a model that others have used and adapted: the Champlain Model for Improving Access to Quality Cancer Surgery, the Primary Care Atom, and Hot Spot, a quarterly palliative care educational publication.
3.4. Evaluation
Of the 19 projects, 16 reported having used formal evaluation methods, 2 reported that their evaluation methods were in development, and 1 reported no formal evaluation method. Among the several evaluation methods used (Table ii), surveys and monitoring of a clinically-relevant time interval were the most common strategies. Table iii lists the outcomes considered in the evaluation. As can be seen, outcomes focused mostly on process measures (for example, progress to goal) or clinical surrogates (number of screens, for instance) rather than on patient-relevant outcomes (for example, quality of life, survival).
TABLE II.
Evaluation tactic | Frequency |
---|---|
Survey | 7 |
Clinical process time interval (for example, wait time) | 4 |
Participation rate (for example, screening rate) | 4 |
Focus group | 3 |
Interview | 2 |
Clinical chart audit | 2 |
Qualitative thematic analysis | 1 |
Volume | 1 |
TABLE III.
Outcome type | Example |
---|---|
Clinically-oriented rate | Screening rate |
Recurrence rate | |
Clinically-oriented frequency | Pain assessments completed (n) |
esas completed (n) | |
Hospital visits (n) | |
Office visits (n) | |
Wait-time interval | To treatment |
To referral | |
To diagnosis | |
Participation rate | By physicians |
By mentors or mentees | |
By centres | |
Knowledge | Clinician |
Satisfaction | Clinician |
Study participant | |
Confidence | Clinician |
Process | Progress toward goal? |
Learning objectives met? | |
Desired effect achieved? |
esas = Edmonton Symptom Assessment System.
3.5. Barriers
Using the barrier assessment process described in the Knowledge-to-Action Cycle 21, and informed by the organizational framework of Légaré et al.18, Table iv outlines the key barriers reported in implementation and evaluation of the projects. Four themes emerged:
Knowledge-related barriers included a lack of awareness of or familiarity with the problem or the solution to the problem.
Attitudes and motivational barriers emerged when a disconnect was observed between proposed solutions and the values of the stakeholders or when confidence that the solutions would work was lacking
Lack of behavioural compliance created a barrier in some projects.
External barriers included challenges to acceptance by patients, organizational challenges, and incongruence with normative context.
TABLE IV.
Descriptive criteria | Frequency |
---|---|
Knowledge | 11 |
Lack of awareness | |
Lack of familiarity | |
Forgetting | |
Attitudes/motivation | 7 |
Lack of agreement (for example, value of the knowledge) | |
Lack of applicability (for example, context or patient factors) | |
Lack of expectancy (belief that efforts will not yield desired effects) | |
Behaviour | 5 |
External barriers | 16 |
Factors associated with patients (for example, different values or preferences) | |
Challenges associated with knowledge use as an innovation (for example, not part of normative context) | |
Factors associated with environmental factors (for example, insufficient funding, staff, time) |
Between 2 and 4 barriers were identified for each of the 19 projects. Environmental barriers, organizational barriers such as insufficient financial resources (particularly related to the sustainability of the project and to the education or training of participants), and barriers associated with the inherent challenges of coordination and administration of a project and challenging group dynamics (for example, individuals not motivated to change) were most commonly cited.
3.6. Tools
Tools were developed by 4 projects, including educational materials (Cancer Word Book, Early Warning Signs teaching wheel, patient materials) and data collection and reporting tools (Interactive Symptom Assessment and Collection, mtuitive pathology report module).
3.7. Lessons Learned
Three themes emerged across the projects with regard to lessons learned.
3.7.1. Collaborative High-Functioning Team
Almost all participants indicated the need to bring together the appropriate partners, from the beginning, to facilitate buy-in, encourage commitment, and enable change. The team had to be composed not only of people responsible for the design, execution, and evaluation of the project, but also of those individuals (patients, health care providers, managers) who would be affected. Further, the need for outstanding leadership (commitment, expertise) and qualified staff support were also considered key defining features of an effective team. Resources to support a high-functioning team included clear terms of reference, a well-articulated and agreed-on communication strategy among and for participants, and a well-articulated and agreed-on dissemination plan to communicate findings to relevant stakeholders.
3.7.2. Project Management
Almost all participants indicated the importance of project planning. Starting with agreement about the problem to solve, the teams learned the value of the explicit articulation of methods, responsibilities, expectations, goals, and a system to evaluate progress toward goals and outcomes. Process mapping and risk mitigation plans were identified as tactics to ensure that duplication was averted, efficiencies were achieved, and alternative strategies were available should the original path prove to be no longer appropriate or viable.
With regard to implementation, pilot-testing was seen as essential, as was incorporation into—or at least minimal disruption of—established work flows.
3.7.3. Support
Participants identified a need for the project to be well supported. Support was conceptualized from several perspectives, including appropriate and predictable funding, access to reliable information technology, ability to engage people with appropriate expertise, access to training and education opportunities for participants, and rewards (including nonfinancial rewards) for work completed. Support from the organization and its leadership were also seen as critical components to enable and sustain change.
4. DISCUSSION
Knowledge Translation for Cancer Control in Canada: A Casebook highlights 30 in-the-field projects, 19 of which are profiled in greater detail, that aim to improve cancer control in Canada. The importance of field projects is that, through them, individuals can see tangible examples of quality improvement work in action. The profiles offer practical direction (including strategies to pursue and to avoid) for other teams and organizations facing similar problems. The complete casebook is now available for the cancer community in Canada, with substantial details about specific projects, processes, lessons learned, and complementary tools and materials 20.
Going beyond traditional research studies to consider practical examples and solutions to problems outside of one’s own jurisdiction has also entered into the practice guideline development arena, particularly when the quality and quantity of research evidence is modest and the practice guideline is targeting organizational or system-wide issues 22. For example, Cancer Care Ontario’s cancer guideline program, the Program in Evidence-Based Care, has used in-the-field cases to inform the development of recommendations for models of diagnostic assessment program requirements 23, systemic therapy 24, and others. A casebook approach by the Canadian Institutes for Health Research profiles excellence in the practice of kt and acts as an end-of-grant dissemination activity 25. The use of the “case” as a teaching tool is quite common in other disciplines such as education 26 and business 27. Further study into optimizing the value of a field project as a solution for application in other contexts or as a teaching tool is required.
We believe that field projects can be important complements to the knowledge emerging from more traditional research models. However, rather than placing field studies and research studies into individual silos, we would argue that a more purposeful interaction between the two can optimize the value of each. Consider, for example, that although most of the casebook projects were not explicitly driven by the science or practice of kt, the results of our analysis demonstrate key features that align with that discipline. For example, defining the features of a collaborative high-functioning team, as part of lessons learned, reflects the core principles of an integrated kt approach 17. These types of collaborations are discussed extensively within kt research contexts and are purposefully integrated into research proposals. Quite similarly, though, the notion that knowledge developers and knowledge users need to work collaboratively to identify and solve problems of interest is also embraced in the context of field projects. Indeed, as discussed by the project leads, this style of collaboration was seen as instrumental to increasing commitment and capacity to change.
Similarly, several of the barriers articulated by the project participants aligned with those recommended by the kt field for consideration and management during implementation efforts. Systematic reviews of the literature demonstrate a lack of knowledge about and awareness of problem and solution; beliefs that actions will not result in desired outcomes; lack of motivation; and environments not conducive to or supportive of change. All of those barriers have been shown empirically to hinder the uptake of new knowledge. And those are precisely the findings reported by casebook participants. Indeed, we found good congruity between the barriers reported by casebook participants and by the Légaré systematic review and Knowledge-to-Action Cycle 19,21. So too, several of the process management and support features identified in the lessons learned aligned with enablers that facilitate uptake of new knowledge 19,21. However, in contrast with research findings, barriers associated with self-efficacy were less likely to be reported. Given that many of the projects were organizational in focus, it is not surprising that organizational features (funding, coordination, and leadership, for instance) were the most notable issues reported.
However, a purposeful consideration of key issues supported by kt research may enhance the quality of in-the-field projects and increase the likelihood of high-quality planning, smooth execution, and increased effectiveness. The goal here is not to transform local efforts into research exercises, but rather to enable a transfer of what has been learned by the kt scientific community into practice and to promote uptake of kt research findings by individuals in the field. To that end, the kt scientific community has a responsibility to create accessible and useful tools and deliverables that enable its new knowledge to be used. Tools to support the application of field solutions from one jurisdiction to another are also warranted if the potential value of the casebook is to be realized. Resources exist (for example, the Canadian Partnership Against Cancer’s Capacity Enhancement Program 28), but a more deliberate effort to integrate these resources into practical field projects is warranted.
The relationship between the kt research community and the field community is not unidirectional. In-the-field projects and individual case studies of quality improvement projects can provide excellent environments from which to generate hypotheses, to investigate the external validity of new knowledge emerging from the field, and to help guide research priorities and open new directions. More deliberate efforts are warranted to facilitate greater acceptance of the value of field projects.
6. SUMMARY
Knowledge Translation for Cancer Control in Canada: A Casebook provides a potentially valuable resource to facilitate and inspire quality improvement in the oncology field. The complementarity of kt practice and kt research can help to meet the goal of closing the “know–do” gap, leading to improvements in health care outcomes and health care systems performance.
7. ACKNOWLEDGMENTS
The authors acknowledge the research team for the casebook initiative and the members of the KT for Cancer Control Best Practices Expert Panel for their guidance and invaluable contributions. The Best Practices Expert Panel members include Dr. George Browman, Dr. Laurie Elit, Ms. Rosmin Esmail, Dr. Ian Graham, Dr. Neil Hagen, Dr. Cheryl Levitt, Dr. George Pasut, Dr. Jill Petrella, Dr. Carol Rand, and Dr. Carol Sawka.
Footnotes
8. CONFLICT OF INTEREST DISCLOSURES
Knowledge Translation for Cancer Control in Canada: A Casebook was part of an overall Knowledge Translation for Cancer Control in Canada research study, conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario.
The Canadian Partnership Against Cancer also supported Knowledge Translation for Cancer Control in Canada: A Casebook through funding provided by the Government of Canada.
MCB, JM, and KG were directly involved in the preparation of this manuscript. SB, TH, and JM were responsible for data collection and compilation of the casebook. MCB, JM, and KG undertook the thematic analysis of the field projects.
9. REFERENCES
- 1.Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71. doi: 10.1056/NEJM199305133281901. [Erratum in: N Engl J Med 1993;329:672] [DOI] [PubMed] [Google Scholar]
- 2.Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7. doi: 10.1016/S0140-6736(96)03386-7. [DOI] [PubMed] [Google Scholar]
- 3.Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–71. doi: 10.1016/S0140-6736(96)03430-7. [DOI] [PubMed] [Google Scholar]
- 4.Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–7. doi: 10.1056/NEJM200011303432203. [DOI] [PubMed] [Google Scholar]
- 5.Verma S, Trudeau M, Pritchard K, Oliver T, members of the Breast Cancer Disease Site Group . Toronto, ON: Cancer Care Ontario, Program in Evidence-Based Care; 2003. The Role of the Taxanes in the Management of Metastatic Breast Cancer. Practice guideline report 1-3. Ver. 2.2003. [Available online at: www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=34140; cited February 5, 2011] [Google Scholar]
- 6.Trudeau M, Eisen A, Messersmith H, Pritchard KI, the Breast Cancer Disease Site Group . Toronto, ON: Cancer Care Ontario, Program in Evidence-Based Care; 2006. Adjuvant Taxane Therapy for Women with Early-Stage, Invasive Breast Cancer: A Clinical Practice Guideline. Sec. 1. Evidence-based series 1-7. [Available online at: www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=34128; cited February 5, 2011] [Google Scholar]
- 7.Trudeau M, Sinclair S, Clemons M, Shelley W, members of the Breast Cancer Disease Site Group . Toronto, ON: Cancer Care Ontario, Program in Evidence-Based Care; 2004. The Role of Taxanes in Neoadjuvant Chemotherapy for Women with Non-metastatic Breast Cancer. Practice guideline report 1-20. [Available online at: www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13886; cited February 5, 2011] [Google Scholar]
- 8.Crump M, Trudeau M, Sinclair S, O’Malley F, members of the Breast Cancer Disease Site Group . The Role of Trastuzumab (Herceptin) in the Treatment of Women with HER2/neu-Over-expressing Metastatic Breast Cancer. Toronto, ON: Cancer Care Ontario, Program in Evidence-Based Care; 2005. Practice guideline report 1-15. Ver. 2.2004. [Available online at: www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=13870; cited February 5, 2011] [Google Scholar]
- 9.Fallon M, Cherny NI, Hanks G. Opioid analgesic therapy. In: Hanks G, Cherny NI, Christakis NA, Fallon M, Kaasa S, Portenoy RK, editors. Oxford Textbook of Palliative Medicine. 4th ed. New York, NY: Oxford University Press; 2010. pp. 661–98. [Google Scholar]
- 10.Francke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Med Inform Decis Mak. 2008;8:38. doi: 10.1186/1472-6947-8-38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Cancer Care Ontario, Cancer Quality Council of Ontario. Cancer System Quality Index 2010 [Web page] Toronto, ON: Cancer Care Ontario; 2010. [Available at: http://csqi.cancercare.on.ca/cms/one.aspx?portalId=63405&pageId=63412; cited February 15, 2011] [Google Scholar]
- 12.Canada, Canadian Institutes of Health Research (cihr) More About Knowledge Translation at CIHR [Web page] Ottawa, ON: cihr; 2010. [Available at: www.cihr-irsc.gc.ca/e/39033.html; cited December 16, 2010] [Google Scholar]
- 13.Straus SE, Tetroe J, Graham ID, editors. Knowledge Translation in Health Care: Moving from Evidence to Practice. Chichester, UK: Wiley–Blackwell Publishing/BMJ; 2009. [Google Scholar]
- 14.Brouwers M, De Vito C, Carol A, et al. Toronto, ON: Cancer Care Ontario, Program in Evidence-Based Care; 2009. Interventions to Increase the Uptake of Cancer Screening. Evidence-based series 15-7. [Available online at: www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=43168; cited December 16, 2010] [Google Scholar]
- 15.Brouwers MC, Makarski J. Knowledge Translation to Improve Quality of Cancer Control in Canada: What We Know and What Is Next. Toronto, ON: Cancer Care Ontario, Program in Evidence-Based Care; Final report. [in press]. [Google Scholar]
- 16.Beyea SC, Nicoll LH. Is it research or quality improvement? AORN J. 1998;68:117–19. doi: 10.1016/S0001-2092(06)62732-4. [DOI] [PubMed] [Google Scholar]
- 17.KT Clearinghouse. Quality Improvement and How It Relates to Knowledge Translation [Web page] Ottawa, ON: Knowledge Translation Canada; n.d. [Available at: ktclearinghouse.ca/knowledgebase/knowledgetoaction/action/interventions/strategies/qualityimprovement; cited December 16, 2010] [Google Scholar]
- 18.Canada, Canadian Institutes of Health Research (cihr) CIHR – Call for KT Casebook [Web page] Ottawa, ON: cihr; 2007. [Available at: www.cihr-irsc.gc.ca/e/33933.html; cited January 14, 2011] [Google Scholar]
- 19.Légaré F, Ratté S, Gravel K, Graham ID. Barriers and facilitators to implementing shared decision-making in clinical practice: update of a systematic review of health professionals’perceptions. Patient Educ Couns. 2008;73:526–35. doi: 10.1016/j.pec.2008.07.018. [DOI] [PubMed] [Google Scholar]
- 20.Brouwers M, Makarski J, Browman G, et al. Knowledge Translation for Cancer Control in Canada: A Casebook. Hamilton, ON: Cancer Care Ontario, Ontario Institute for Cancer Research; 2010. [Available at: www.cancerguidelines.ca/Guidelines/casebook/documents/casebook.pdf; cited December 16, 2010] [Google Scholar]
- 21.Graham ID, Logan J, Harrison MB, et al. Lost in knowledge translation: time for a map? J Contin Educ Health Prof. 2006;26:13–24. doi: 10.1002/chp.47. [DOI] [PubMed] [Google Scholar]
- 22.Browman GP, Brouwers M, Fervers B, Sawka C. Population-based cancer control and the role of guidelines—towards a “systems” approach. In: Elwood JM, Sutcliffe SB, editors. Cancer Control. Oxford, U.K: Oxford University Press; 2009. [Google Scholar]
- 23.Brouwers M, Oliver TK, Crawford J, et al. Cancer diagnostic assessment programs: standards for the organization of care in Ontario. Curr Oncol. 2009;16:29–41. doi: 10.3747/co.v16i6.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Vandenberg T, Coakley N, Nayler J, et al. A framework for the organization and delivery of systemic treatment. Curr Oncol. 2009;16:4–15. doi: 10.3747/co.v16i1.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Canada, Canadian Institutes of Health Research (cihr) Knowledge to Action: A Knowledge Translation Casebook [Web page] Ottawa, ON: cihr; 2009. [Available at: www.cihr-irsc.gc.ca/e/38764.html; cited January 14, 2011] [Google Scholar]
- 26.Merriam SB. Qualitative Research and Case Study Applications in Education. 2nd ed. San Francisco, CA: Jossey–Bass Publishers; 1998. [Google Scholar]
- 27.Barnes LB, Christensen CR, Hansen AJ. Teaching and the Case Method: Text, Cases, and Readings. 3rd ed. Boston, MA: Harvard Business School Press; 1994. [Google Scholar]
- 28.Canadian Partnership Against Cancer. Guidelines Capacity Enhancement Program [Web page] Toronto, ON: Canadian Partnership Against Cancer; n.d. [Available at: www.partnershipagainstcancer.ca/priorities/cancer-guidelines/strategic-initiatives/guidelines-capacity-enhancement/; cited December 16, 2010] [Google Scholar]